GE HealthCare Technologies Inc.
NASDAQ:GEHCMedical - Healthcare Information Services
+$0.45 today
- Market cap
- $37.83B
- Beta
- 0.86
- P/E (TTM)
- 18.7
- EPS (TTM)
- $3.30
- Dividend yield
- 0.23%
Volume 3.65M
Average 4.84M
GEHC Net Income
Bottom-line profit, the starting point for calculating cash from operations.
GE HealthCare Technologies Inc.NASDAQ: GEHC
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income growth accelerates
Q2 FY2026 net income of $574M rose 14.8% year over year, ahead of the -12.0% change in trailing-twelve-month net income. Sequentially, it rose 39.7% from the prior quarter. Over 3 fiscal years it compounded at +3.4% a year.
Context
- Net income amounted to 10.4% of revenue in FY2025, unchanged from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 16 analysts of $2.31B (+7.4%) for the fiscal year ending Dec 2026, a step up from the +5.1% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $574M+39.7% QoQ
- Last fiscal yearDec 2025
- $2.15B+5.1% YoY
- LTMJun 2026
- $2.04B-12.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +14.8% | +17.6% | +2.8 pp |
| 1 year | +5.1% | +7.4% | +2.3 pp |
| 3-year CAGR | +3.4% | +8.5% | +5.2 pp |
| 5-year CAGR | +10.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 2.15B USD
- Year-over-year change
- +5.1%
- 4-year CAGR
- -1.4%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.15B | +5.1% |
| FY2024 | 2024-12-31 | 2.05B | +26.7% |
| FY2023 | 2023-12-31 | 1.62B | -17.0% |
| FY2022 | 2022-12-31 | 1.95B | -14.3% |
| FY2021 | 2021-12-31 | 2.28B | — |
Net Income vs competitors
How GEHC compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -12.0% is the 5th highest of 6, against a peer median of +27.8%.
- Net income amounts to 10.1% of revenue for GEHC, versus a peer median of 14.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $5.43B USD | -61.2% | -2.0% | 11.6% | |
| LTM Jul 2026 | $5.27B USD | +12.7% | +8.5% | 14.0% | |
| LTM Jun 2026 | $3.73B USD | +27.8% | +11.2% | 14.4% | |
| LTM Jun 2026 | $3.67B USD | +34.6% | +60.6% | 17.5% | |
| LTM Jun 2026 | $2.04B USD | -12.0% | +3.4% | 10.1% | |
| LTM Jun 2026 | €1.12B EUR | +541.7% | — | 6.3% | |
| Peer median (excluding GEHC) | — | +27.8% | +9.9% | 14.0% | |
Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.28B | 1.95B | 1.62B | 2.05B | 2.15B |
| Depreciation & Amortization | 625M | 633M | 610M | 580M | 578M |
| Deferred Income Tax | 600M | 563M | 743M | 531M | 0 |
| Stock-Based Compensation | 76M | 67M | 114M | 125M | 130M |
| Change in Working Capital | (1.37B) | (293M) | 22M | (59M) | (357M) |
| Accounts Receivables | (1.16B) | (440M) | (171M) | (150M) | (216M) |
| Inventory | (435M) | (402M) | 111M | (81M) | (142M) |
| Accounts Payables | 263M | 481M | (13M) | 126M | 90M |
| Other Working Capital | (42M) | 68M | 95M | 46M | (89M) |
| Other Non-Cash Items | (599M) | (806M) | (1.01B) | (1.28B) | (517M) |
| Operating Cash Flow | 1.61B | 2.11B | 2.1B | 1.95B | 1.99B |
| Capital Expenditures | (248M) | (310M) | (387M) | (401M) | (482M) |
| Acquisitions (Net) | (1.48B) | 0 | (147M) | (313M) | 0 |
| Purchases of Investments | 0 | (59M) | (48M) | (40M) | (118M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (32M) | (29M) | 24M | (160M) | (447M) |
| Investing Cash Flow | (1.76B) | (398M) | (558M) | (914M) | (1.05B) |
| Debt Repayment | (12M) | 8.2B | 1.14B | (423M) | 967M |
| Common Stock Issued | 0 | 0 | 0 | 33M | 37M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (200M) |
| Dividends Paid | 0 | 0 | (41M) | (55M) | (64M) |
| Other Financing Activities | (251M) | (9.03B) | (1.58B) | (128M) | (123M) |
| Financing Cash Flow | (263M) | (822M) | (478M) | (573M) | 617M |
| Effect of Forex Changes | (34M) | (3M) | (10M) | (77M) | 64M |
| Net Change in Cash | (451M) | 890M | 1.06B | 387M | 1.62B |
| Free Cash Flow | 1.36B | 1.8B | 1.71B | 1.55B | 1.51B |
GE HealthCare Technologies Inc.
NASDAQ:GEHC
Intrinsic Alpha fair value
Locked
Current Price
$83.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.